Literature DB >> 19659777

Level of major histocompatibility complex class I expression on endothelium in non-obese diabetic mice influences CD8 T cell adhesion and migration.

B Lozanoska-Ochser1, M Peakman.   

Abstract

An important prerequisite for development of insulitis and beta-cell destruction in type 1 diabetes is successful transmigration of autoreactive T cells across the islet endothelium. Previous work suggests that antigen presentation to T cells by endothelium, which requires endothelial cell expression of major histocompatibility complex (MHC) molecules, promotes tissue-specific T cell migration. We therefore tested the hypothesis that the level of endothelial MHC class I molecule expression in diabetes-prone mice directly influences autoreactive CD8 T cell migration. We investigated the immune phenotype of endothelial cells, focusing on endothelial MHC class I molecule expression in a range of different tissues and mouse strains, including non-obese diabetic (NOD) mice. In addition, we examined whether the level of expression of MHC class I molecules influences autoantigen-driven CD8 T cell transmigration. Using endothelial cell lines that expressed 'high' (NOD mouse), medium (NOD x C3H/HeJ F(1) generation mice) and no (C3H/HeJ) H-2K(d), we demonstrated in vitro that MHC levels have a profound effect on the activation, adhesion and transmigration of pathogenic, islet autoreactive CD8 T cells. The expression level of MHC class I molecules on endothelial tissues has a direct impact upon the efficiency of migration of autoreactive T cells. The immune phenotype of microvascular endothelium in NOD mice may be an additional contributory factor in disease predisposition or development, and similar phenotypes should be sought in human type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19659777      PMCID: PMC2710599          DOI: 10.1111/j.1365-2249.2009.03940.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

Review 1.  Immunobiology of human vascular endothelium.

Authors:  J S Pober
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  The NOD mouse: a model of immune dysregulation.

Authors:  Mark S Anderson; Jeffrey A Bluestone
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

3.  Atorvastatin fails to prevent the development of autoimmune diabetes despite inhibition of pathogenic beta-cell-specific CD8 T-cells.

Authors:  Biliana Lozanoska-Ochser; Francesca Barone; Costantino Pitzalis; Mark Peakman
Journal:  Diabetes       Date:  2006-04       Impact factor: 9.461

Review 4.  Human endothelial cell presentation of antigen and the homing of memory/effector T cells to skin.

Authors:  J S Pober; M S Kluger; J S Schechner
Journal:  Ann N Y Acad Sci       Date:  2001-09       Impact factor: 5.691

5.  Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: close correlation between serological markers and histological evidence of cellular autoimmunity.

Authors:  A Imagawa; T Hanafusa; S Tamura; M Moriwaki; N Itoh; K Yamamoto; H Iwahashi; K Yamagata; M Waguri; T Nanmo; S Uno; H Nakajima; M Namba; S Kawata; J I Miyagawa; Y Matsuzawa
Journal:  Diabetes       Date:  2001-06       Impact factor: 9.461

6.  Spontaneous T-cell proliferation in the non-obese diabetic mouse to a peptide from the unique class II MHC molecule, I-Ag7, which is also protective against the development of autoimmune diabetes.

Authors:  X J Xu; C Gearon; E Stevens; D Vergani; H Baum; M Peakman
Journal:  Diabetologia       Date:  1999-05       Impact factor: 10.122

7.  Lymphocyte vaccination protects prediabetic non-obese diabetic mice from developing diabetes mellitus.

Authors:  C L Gearon; M J Hussain; D Vergani; M Peakman
Journal:  Diabetologia       Date:  1997-12       Impact factor: 10.122

8.  TLR ligands and cytokines induce CXCR3 ligands in endothelial cells: enhanced CXCL9 in autoimmune arthritis.

Authors:  Tamara Loos; Lies Dekeyzer; Sofie Struyf; Evemie Schutyser; Klara Gijsbers; Mieke Gouwy; Annelies Fraeyman; Willy Put; Isabelle Ronsse; Bernard Grillet; Ghislain Opdenakker; Jo Van Damme; Paul Proost
Journal:  Lab Invest       Date:  2006-07-17       Impact factor: 5.662

9.  Lymphocyte vaccination prevents spontaneous diabetes in the non-obese diabetic mouse.

Authors:  R A Smerdon; M Peakman; M J Hussain; D Vergani
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

10.  Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile.

Authors:  N Somoza; F Vargas; C Roura-Mir; M Vives-Pi; M T Fernández-Figueras; A Ariza; R Gomis; R Bragado; M Martí; D Jaraquemada; R Pujol-Borrell
Journal:  J Immunol       Date:  1994-08-01       Impact factor: 5.422

View more
  7 in total

Review 1.  Immune cell trafficking to the islets during type 1 diabetes.

Authors:  A M Sandor; J Jacobelli; R S Friedman
Journal:  Clin Exp Immunol       Date:  2019-08-30       Impact factor: 4.330

Review 2.  Immunopathology of the human pancreas in type-I diabetes.

Authors:  Sarah J Richardson; Abby Willcox; Adrian J Bone; Noel G Morgan; Alan K Foulis
Journal:  Semin Immunopathol       Date:  2010-04-28       Impact factor: 9.623

Review 3.  Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.

Authors:  S Scott Whitmore; Elliott H Sohn; Kathleen R Chirco; Arlene V Drack; Edwin M Stone; Budd A Tucker; Robert F Mullins
Journal:  Prog Retin Eye Res       Date:  2014-12-05       Impact factor: 21.198

Review 4.  Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis.

Authors:  Sherman S Leung; Josephine M Forbes; Danielle J Borg
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

5.  Alteration of the thymic T cell repertoire by rotavirus infection is associated with delayed type 1 diabetes development in non-obese diabetic mice.

Authors:  Nicole L Webster; Christel Zufferey; Jessica A Pane; Barbara S Coulson
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

Review 6.  An evolving new paradigm: endothelial cells--conditional innate immune cells.

Authors:  Jietang Mai; Anthony Virtue; Jerry Shen; Hong Wang; Xiao-Feng Yang
Journal:  J Hematol Oncol       Date:  2013-08-22       Impact factor: 17.388

Review 7.  T Lymphocyte-Endothelial Interactions: Emerging Understanding of Trafficking and Antigen-Specific Immunity.

Authors:  Christopher V Carman; Roberta Martinelli
Journal:  Front Immunol       Date:  2015-11-24       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.